鎮痛剤は痛みを和らげるために使用され、脳への痛みの信号の伝達を遮断または軽減することによって、あるいは脳の痛みの認識を変えることによって作用します。鎮痛薬には、非ステロイド性抗炎症薬 (NSAID)、アセトアミノフェン、オピオイド、局所麻酔薬など、いくつかの種類があります。鎮痛剤は指示どおりに使用し、ラベルの指示に従うことが重要です。鎮痛剤の過剰使用または誤用は、肝臓障害、腎臓障害、中毒などの深刻な健康上の問題を引き起こす可能性があります。2022 年における世界の鎮痛薬市場は 516 億 3000 万ドルと評価され、2028 年までに 675 億 5000 万ドルに達すると予想されます。
また、高齢者は痛みやうずきの問題を頻繁に抱えているため、この分野の拡大後押ししています。また、より優れた鎮痛薬を開発するための製薬企業の技術向上によって、将来的には鎮痛薬市場に収益性の高い事業機会が生まれると予想されます。さらに、慢性疼痛の増加、鎮痛薬の製造・販売を行う大手メーカーの増加、市販薬に対する需要の増加、局所鎮痛薬の需要の増加、医療支出の増加などが全て市場の成長に寄与しています。世界の鎮痛薬市場の価値は、2023年から2028年の予測期間中4.6%のCAGRで成長する見込みです。
目次
1. Executive Summary
2. Introduction
2.1 Analgesics: An Overview
2.1.1 Uses of Analgesics
2.2 Analgesics Segmentation: An Overview
2.2.1 Analgesics Segmentation
3. Global Market Analysis
3.1 Global Analgesics Market: An Analysis
3.1.1 Global Analgesics Market: An Overview
3.1.2 Global Analgesics Market by Value
3.1.3 Global Analgesics Market by Drug Class (Opioids and Non Opioids)
3.1.4 Global Analgesics Market by Route of Administration (Oral, Topical, Intravenous, Transdermal and Rectal)
3.1.5 Global Analgesics Market by Region (North America, Europe, Asia Pacific and Rest of the World)
3.2 Global Analgesics Market: Drug Class Analysis
3.2.1 Global Analgesics Market by Drug Class: An Overview
3.2.2 Global Opioids Analgesics Market by Value
3.2.3 Global Non Opioids Analgesics Market by Value
3.3 Global Analgesics Market: Route of Administration Analysis
3.3.1 Global Analgesics Market by Route of Administration: An Overview
3.3.2 Global Oral Analgesics Market by Value
3.3.3 Global Topical Analgesics Market by Value
3.3.4 Global Intravenous Analgesics Market by Value
3.3.5 Global Transdermal Analgesics Market by Value
3.3.6 Global Rectal Analgesics Market by Value
4. Regional Market Analysis
4.1 North America Analgesics Market: An Analysis
4.1.1 North America Analgesics Market: An Overview
4.1.2 North America Analgesics Market by Value
4.1.3 North America Analgesics Market by Route of Administration (Topical and Others)
4.1.4 North America Topical and Others Analgesics Market by Value
4.1.5 North America Analgesics Market by Region (The US, Canada and Mexico)
4.1.6 The US Analgesics Market by Value
4.1.7 Canada Analgesics Market by Value
4.1.8 Mexico Analgesics Market by Value
4.2 Europe Analgesics Market: An Analysis
4.2.1 Europe Analgesics Market: An Overview
4.2.2 Europe Analgesics Market by Value
4.2.3 Europe Analgesics Market by Route of Administration (Topical and Others)
4.2.4 Europe Topical and Others Analgesics Market by Value
4.2.5 Europe Analgesics Market by Region (Germany, UK, Italy, France, Spain and Rest of Europe)
4.2.6 Germany Analgesics Market by Value
4.2.7 UK Analgesics Market by Value
4.2.8 Italy Analgesics Market by Value
4.2.9 France Analgesics Market by Value
4.2.10 Spain Analgesics Market by Value
4.2.11 Rest of Europe Analgesics Market by Value
4.3 Asia Pacific Analgesics Market: An Analysis
4.3.1 Asia Pacific Analgesics Market: An Overview
4.3.2 Asia Pacific Analgesics Market by Value
4.3.3 Asia Pacific Analgesics Market by Route of Administration (Topical and Others)
4.3.4 Asia Pacific Topical and Others Analgesics Market by Value
4.3.5 Asia Pacific Analgesics Market by Region (China, India, Japan, Australia and Rest of Asia Pacific)
4.3.6 China Analgesics Market by Value
4.3.7 India Analgesics Market by Value
4.3.8 Japan Analgesics Market by Value
4.3.9 Australia Analgesics Market by Value
4.3.10 Rest of Asia Pacific Analgesics Market by Value
4.4 Rest of the World Analgesics Market: An Analysis
4.4.1 Rest of the World Analgesics Market: An Overview
4.4.2 Rest of the World Analgesics Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Analgesics Market
5.1.2 Post COVID-19 Impact
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rising Incidence of Acute Chronic Diseases
6.1.2 Increasing Geriatric Population
6.1.3 Upsurge in Healthcare Expenditure
6.1.4 Increased Disposable Income
6.1.5 Upsurge in E-Commerce Sales
6.1.6 Rising Number of Medical Surgeries across the World
6.1.7 Rising Demand for Strong Agonists
6.2 Challenges
6.2.1 Risk of Overdose and Addiction
6.2.2 Increasing Use of Biologics
6.2.3 High Cost of Drug Development
6.3 Market Trends
6.3.1 Use of Artificial Intelligence in Analgesics
6.3.2 Surge in Research & Development in Pharmaceutical Sector
6.3.3 Strategic Collaborations and Technological Development in The Pharmaceutical Industry
6.3.4 Healthier Lifestyles
6.3.5 Rx-to-OTC switches
7. Competitive Landscape
7.1 Global Analgesics Players by Market Share
7.2 Global Systemic Analgesics Players by Market Share
7.3 Global Topical Analgesics Players by Market Share
7.4 Western Europe Analgesics Players by Market Share
7.5 The US Topical Analgesics Players by Market Share
7.6 The US Systemic Analgesics Players by Market Share
8. Company Profiles
8.1 Bayer AG
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 Sanofi S.A.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy
8.3 Pfizer Inc.
8.3.1 Business Overview
8.3.2 Business Segments
8.3.3 Business Strategy
8.4 Abbott Laboratories
8.4.1 Business Overview
8.4.2 Operating Segment
8.4.3 Business Strategy
8.5 Reckitt Benckiser Group PLC
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Johnson & Johnson
8.6.1 Business Overview
8.6.2 Business Segment
8.6.3 Business Strategy
8.7 Haleon PLC
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy
8.8 TEVA Pharmaceutical Industries Limited
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy
8.9 Sun Pharmaceutical Industries Ltd.
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy
8.10 Endo International Plc.
8.10.1 Business Overview
8.10.2 Operating Segment
8.10.3 Business Strategy
8.11 GlaxoSmithKline Plc
8.11.1 Business Overview
8.11.2 Sales by Products
8.11.3 Business Strategies
8.12 Eli Lilly and Company
8.12.1 Business Overview
8.12.2 Revenue by Products
8.12.3 Business Strategy
List of Figures
Figure 1: Uses of Analgesics
Figure 2: Analgesics Segmentation
Figure 3: Global Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Analgesics Market by Drug Class; 2022 (Percentage, %)
Figure 6: Global Analgesics Market by Route of Administration; 2022 (Percentage, %)
Figure 7: Global Analgesics Market by Region; 2022 (Percentage, %)
Figure 8: Global Opioids Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 9: Global Opioids Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 10: Global Non Opioids Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 11: Global Non Opioids Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 12: Global Oral Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 13: Global Oral Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 14: Global Topical Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 15: Global Topical Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 16: Global Intravenous Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 17: Global Intravenous Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 18: Global Transdermal Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 19: Global Transdermal Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 20: Global Rectal Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 21: Global Rectal Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 22: North America Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 23: North America Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 24: North America Analgesics Market by Route of Administration; 2022 (Percentage, %)
Figure 25: North America Topical and Others Analgesics Market by Value; 2021-2028 (US$ Billion)
Figure 26: North America Analgesics Market by Region; 2022 (Percentage, %)
Figure 27: The US Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 28: The US Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 29: Canada Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 30: Canada Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 31: Mexico Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 32: Mexico Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 33: Europe Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 34: Europe Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 35: Europe Analgesics Market by Route of Administration; 2022 (Percentage, %)
Figure 36: Europe Topical and Others Analgesics Market by Value; 2021-2028 (US$ Billion)
Figure 37: Europe Analgesics Market by Region; 2022 (Percentage, %)
Figure 38: Germany Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 39: Germany Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 40: UK Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 41: UK Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 42: Italy Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 43: Italy Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 44: France Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 45: France Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 46: Spain Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 47: Spain Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 48: Rest of Europe Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 49: Rest of Europe Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 50: Asia Pacific Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 51: Asia Pacific Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 52: Asia Pacific Analgesics Market by Route of Administration; 2022 (Percentage, %)
Figure 53: Asia Pacific Topical and Others Analgesics Market by Value; 2021-2028 (US$ Million)
Figure 54: Asia Pacific Analgesics Market by Region; 2022 (Percentage, %)
Figure 55: China Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 56: China Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 57: India Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 58: India Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 59: Japan Analgesics Market by Value; 2018-2022 (US$ Million)
Figure 60: Japan Analgesics Market by Value; 2023-2028 (US$ Million)
Figure 61: Australia Analgesics Market by Value; 2018-2022 (US$ Million)
Figure 62: Australia Analgesics Market by Value; 2023-2028 (US$ Million)
Figure 63: Rest of Asia Pacific Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 64: Rest of Asia Pacific Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 65: Rest of the World Analgesics Market by Value; 2018-2022 (US$ Billion)
Figure 66: Rest of the World Analgesics Market by Value; 2023-2028 (US$ Billion)
Figure 67: Global Number of People with Diabetes in Adults (20-79 Years) by Region; 2021 & 2045 (Million)
Figure 68: Global Percentage of Population Aged 65 Years or Over; 2016, 2021 & 2050 (Percentage, %)
Figure 69: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 70: Global GNI per Capita; 2016-2021 (US$ Million)
Figure 71: Global E-commerce as % of sales in Consumer Health; 2013-2021 (Percentage, %)
Figure 72: Global Market Size for Artificial Intelligence in Healthcare; 2021-2030 (US $Billion)
Figure 73: Global Pharmaceutical Research and Development Spending; 2019-2028 (US$ Billion)
Figure 74: Global Analgesics Players by Market Share; 2022 (Percentage, %)
Figure 75: Global Systemic Analgesics Players by Market Share; 2022 (Percentage, %
Figure 76: Global Topical Analgesics Players by Market Share; 2022 (Percentage, %)
Figure 77: Western Europe Analgesics Players by Market Share; 2022 (Percentage, %)
Figure 78: The US Topical Analgesics Players by Market Share; 2022 (Percentage, %)
Figure 79: The US Systemic Analgesics Players by Market Share; 2022 (Percentage, %)
Figure 80: Bayer AG Net Sales by Segment; 2022 (Percentage, %)
Figure 81: Sanofi S.A. Net Sales by Segments; 2022 (Percentage, %)
Figure 82: Pfizer Inc. Revenue by Segment; 2022 (Percentage, %)
Figure 83: Abbott Laboratories Revenue by Segment; 2022 (Percentage, %)
Figure 84: Reckitt Benckiser Group PLC Net Revenue by Segment; 2022 (Percentage, %)
Figure 85: Johnson & Johnson Sales by Business Segment; 2022 (Percentage, %)
Figure 86: Haleon PLC Revenue by Segment; 2022 (Percentage, %)
Figure 87: TEVA Pharmaceutical Industries Ltd., Revenues by Segment; 2021 (Percentage, %)
Figure 88: Sun Pharmaceutical Industries Ltd. Revenue by Segment; 2022 (Percentage, %)
Figure 89: Endo International Plc. Revenue by Segment; 2021 (Percentage, %)
Figure 90: GlaxoSmithKline Plc. Sales by Products; 2022 (Percentage, %)
Figure 91: Eli Lilly and Company Revenue by Products; 2022 (Percentage, %)
Table 1: Rx-to-OTC switches in the US list
